Clinical Trial Update: A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a phase 1/2 study of MK-1084 in combination with other treatments for non-small cell lung cancer (MK-3475-01F), currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• MK-1084

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Lung Neoplasm Malignant | Phase 1, Phase 2 | Status: RECRUITING